Abstract: Disclosed herein are chemokine receptor antagonists of formula (I) wherein R1, R2, and R3 are as defined in the specification. Compositions comprising such compounds; and methods for treating conditions and disorders using such compounds and compositions are also described.

Abstract: A low-sodium salt composition includes a carrier particle having disposed thereon a plurality of salt crystallites of an average size of less than about 20 microns. The low-sodium salt compositions are useful as salt-alternative products that impart a salty taste with less sodium content than an equivalent volume of sodium chloride by itself.

Abstract: The present invention includes arginase enzyme inhibitors, compositions comprising these arginase inhibitors, and methods of treating or diagnosing conditions characterized either by abnormally high arginase activity or abnormally low nitric oxide levels in a mammal, comprising administering compositions of the invention to the mammal.

Abstract: Disclosed herein are chemokine receptor antagonists of formula (I) wherein R1, R2, and R3 are as defined in the specification. Compositions comprising such compounds; and methods for treating conditions and disorders using such compounds and compositions are also described.

Abstract: The present invention includes arginase enzyme inhibitors, compositions comprising these arginase inhibitors, and methods of treating or diagnosing conditions characterized either by abnormally high arginase activity or abnormally low nitric oxide levels in a mammal, comprising administering compositions of the invention to the mammal.

Abstract: The present invention relates to the use of a composition made from Clerodendrum for treating tic disorder or sensorimotor gating deficits, wherein the composition is particularly made from the leaves of the plant.

Abstract: The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity.

Abstract: Provided herein are 1-oxa-8-azaspiro[4.5]decane-8-carboxamide compounds of formula I wherein Ar1, Ar2, R1, R2, R3 and R4 are as defined herein and the pharmaceutically acceptable salts of such compounds useful in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity, conditions including acute pain, chronic pain, neuropathic pain, nociceptive pain, inflammatory pain, fibromyalgia, rheumatoid arthritis, inflammatory bowel disease, lupus, diabetes, allergic asthma, vascular inflammation, urinary incontinence, overactive bladder, emesis, cognitive disorders, anxiety, depression, sleeping disorders, eating disorders, movement disorders, glaucoma, psoriasis, multiple sclerosis, cerebrovascular disorders, brain injury, gastrointestinal disorders, hypertension, or cardiovascular disease.

Abstract: Food products are described. In one general aspect, a low-sodium alternative product to table salt is described that provides substantially equal salty flavor as compared with an equal volume of table salt. The low-sodium alternative product includes extremely small salt particles adhered to an edible carrier particle; the increased surface area-to-volume ratio of the product interacts with mouth physiology to provide increased salt flavor as compared to conventional table salt, while substantially reducing the amount of salt ingested by the consumer.

Abstract: The present invention relates to the use of a composition made from Clerodendrum for treating tic disorder or sensorimotor gating deficits, wherein the composition is particularly made from the leaves of the plant.

Abstract: The present invention relates to compounds of Formula (I) wherein Ar is optionally substituted phenyl or 6-membered heteroaryl moiety, or a benzisoxazole, pyrrolopyridine, or benzotriazole group; or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity, including pain, urinary incontinence, overactive bladder, emesis, cognitive disorders, anxiety, depression, sleeping disorders, eating disorders, movement disorders, glaucoma, psoriasis, multiple sclerosis, cerebrovascular disorders, brain injury, gastrointestinal disorders, hypertension, or cardiovascular disease.

Abstract: The present invention relates to compounds of the Formula (I), and pharmaceutically acceptable salts thereof, and their use in the treatment of FAAH-mediated diseases or condition.

Abstract: An ink composition for forming absorbers of thin film cells comprising particles and a chelating agent for the particles. The particles contain a mixture of at least one element or the salts from group IB and/or IIIA and/or VIA. In the present invention, the chelating agent can alternatively be aromatic diamine compounds, alkyl diamine compounds or aliphatic diamine compounds. In addition, the present invention discloses a producing method for the ink composition as well. According to the present invention, the particles can be reacted into a single composition while the existence of the chelating agent, manufacturing the CIGS/CIS films in large scale and simplifying the conventional manufacturing processes are capable of accomplishment.

Abstract: Pilot data and data-bearer data are formed to be mutually orthogonal and in each other's null-space. Data to be transmitted is first modulated with the data-bearer matrix and then pilot data is added thereto. The pilot data may be added to each modulated symbol, thereby increasing significantly the density of pilot information available at the receiver for channel state estimation. When pilot data is added across an entire transmitted block of data, data detection performance is improved for even fast fading Rayleigh fading channels.

Abstract: A composition and process for baked food products is provided to impart the sensorial attributes of fried food products. The composition is in the form of a batter coating, either powdered or wet, which is applied to a food product, and when baked, has the taste, texture and appearance of a fried food product. The batter coating includes at least an enzyme-modified starch or flour or other starch-containing material having oil absorbing capabilities. The enzyme-modified starch is plated with a liquid cooking oil in order to bring the liquid cooking oil into the process, and the batter coating retains the incorporated liquid cooking oil during processing to impart a fat fried texture, appearance and taste to the baked food product.

Abstract: Granular starch is added to a polymer in order to decrease the cost of the polymer derivative. Use of granular starch also makes the derivative more biodegradable. The polymer blend has very similar mechanical properties to pure polymer. Furthermore, unlike other starch/polyethylene mixtures, glycerol is not added to the mixture. This reduces the water absorbency of the final product. The polymer and starch are blended together in the presence of an interfacial compatibilizer that binds the two components together.

Abstract: The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity.

Abstract: A demodulator such as a Fast Hadamard Transform (FHT) based demodulator is used to demodulate all channels in a code space with code length equal to the data channel code. Since the codes for overhead control channels are usually longer, the control channel data is only partially uncovered. Once the necessary further processing is performed and the information to fully uncover the control channels is available, the control channel data is fully demodulated. By only processing one partially uncovered secondary control channel, the present invention reduces the implementation complexity. A hardware implementation of the above method, requires fewer data processing operations, and reduces data processing delays, resulting in lower power consumption.

Abstract: A CDMA receiver (500) minimizes the use of hardware by taking advantage of the fact that Walsh sequences of a predetermined length (e.g., 16) are comprised of inverted and non-inverted versions of smaller length (e.g., 4) sequences. The receiver (500) performs the necessary uncovering operations for example of a Walsh sequence of length 16 by performing uncovering operations using smaller length Walsh sequences such as of length 4 and then performing subsequent summing operations with inverted and non-inverted versions of the results of such uncovering operations.